Grassi, L., Caruso, R., Hammelef, K., et al. (2014). Efficacy and safety of pharmacotherapy in cancer-related psychiatric disorders across the trajectory of cancer care: A review. International Review of Psychiatry, 26, 44–62. https://doi.org/10.3109/09540261.2013.842542

Alma College

Google

Clinicians prescribe medications such as antidepressants and other approved pharmacological resources that seem to be not completely significant, as there are further considerations that prevent the longevity of use as well as the withdrawal factor.  In addition, factors such as the increased risk of attempting suicide which is presented in antidepressants are not reported in clinical trials in which psilocybin is used.

Psylocibin-assisted therapy could become a more successful treatment for mood disorders in patients with terminal illnesses than currently approved treatments

Learn Before

Related